Astrazeneca Plc (AZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,664,000 | 6,232,000 | 6,166,000 | 4,458,000 | 4,817,000 |
| Marketable Securities | 148,000 | 270,000 | 326,000 | 545,000 | 179,000 |
| Receivables | 11,932,000 | 10,797,000 | 11,252,000 | 10,061,000 | 9,612,000 |
| Inventories | 5,051,000 | 4,967,000 | 4,699,000 | 5,078,000 | 6,220,000 |
| Other current assets | 44,000 | 0 | 150,000 | 82,000 | 89,000 |
| TOTAL | $22,839,000 | $22,266,000 | $22,593,000 | $20,224,000 | $20,917,000 |
| Non-Current Assets | |||||
| PPE Net | 8,675,000 | 8,644,000 | 8,507,000 | 8,352,000 | 8,722,000 |
| Investments And Advances | 1,143,000 | 1,350,000 | 1,216,000 | 1,214,000 | 1,293,000 |
| Intangibles | 58,286,000 | 59,292,000 | 59,127,000 | 59,292,000 | 59,721,000 |
| Other Non-Current Assets | 5,600,000 | 5,135,000 | 5,040,000 | 5,103,000 | 5,926,000 |
| TOTAL | $73,704,000 | $74,421,000 | $73,890,000 | $73,961,000 | $75,662,000 |
| Total Assets | $96,543,000 | $96,687,000 | $96,483,000 | $94,185,000 | $96,579,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,556,000 | 3,625,000 | 5,314,000 | 5,408,000 | 2,162,000 |
| Accounts payable and accrued liabilities | 19,738,000 | 19,210,000 | 19,040,000 | 17,694,000 | 17,821,000 |
| Other current liabilities | 650,000 | 590,000 | 815,000 | 445,000 | 631,000 |
| TOTAL | $26,375,000 | $24,860,000 | $26,293,000 | $24,850,000 | $21,815,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 24,329,000 | 26,916,000 | 22,965,000 | 23,013,000 | 26,461,000 |
| Other Non-Current Liabilities | 5,621,000 | 6,305,000 | 7,222,000 | 7,687,000 | 7,077,000 |
| TOTAL | $32,752,000 | $36,016,000 | $33,132,000 | $34,181,000 | $38,813,000 |
| Total Liabilities | $59,127,000 | $60,876,000 | $59,425,000 | $59,031,000 | $60,628,000 |
| Shareholders' Equity | |||||
| Common Shares | 387,000 | 387,000 | 387,000 | 387,000 | 387,000 |
| Retained earnings | -234,000 | -1,825,000 | -574,000 | -2,471,000 | -1,657,000 |
| Other shareholders' equity | 2,100,000 | 2,090,000 | 2,090,000 | 2,101,000 | 2,087,000 |
| TOTAL | $37,416,000 | $35,811,000 | $37,058,000 | $35,154,000 | $35,951,000 |
| Total Liabilities And Equity | $96,543,000 | $96,687,000 | $96,483,000 | $94,185,000 | $96,579,000 |